DOCSLIB.ORG

Ketamine: Dreams and Realities

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Psychology/Spirituality/Popular Culture Karl Jansen M.D., Ph.D. Ketamine: Dreams and Realities Ketamine: Ketamine: Dreams and Realities Ketamine: “Karl Jansen’s book Ketamine: Dreams and Realities is a goldmine of information on this fascinating substance that combines in a unique way the properties of an anesthetic and a psychedelic. It is clearly written, well researched and documented, and presents a balanced and objective view point. The author’s broad perspective, which covers all the aspects of ketamine from pharmacology to its Karl Jansen M.D., Ph.D. use at raves, makes this book interesting for clinicians and researchers, as well as the general public.” LONDON researcher – Stan Grof, M.D., author of Psychology of the Karl Jansen, M.D., Ph.D., Future: Lessons From Modern Consciousness and Member of the Royal Research and LSD Psychotherapy College of Psychiatrists, is the world’s leading expert on “Indispensable reading for those with any interest ketamine. He has studied in ketamine. Entertaining, thought-provoking, ketamine at every level: from photographing the receptors and thorough.” to which ketamine binds in – Rick Strassman, M.D., author of the human brain, while DMT: The Spirit Molecule: A Doctor’s earning his doctorate in Revolutionary Research into the Biology clinical pharmacology at of Near-Death and Mystical Experiences the University of Oxford, to publishing papers on his “It is an excellent book… a well done comprehensive discovery of the similarities review of the entire history of ketamine.” between ketamine’s psycho- Karl Jansen M.D., Ph.D. – Evgeny Krupitsky, M.D., Ph.D. Pioneer researcher active effects and the near- into the use of ketamine-assisted psychotherapy in death experience during his the treatment of alcoholism and heroin addiction study of medicine in New Zealand. Dr. Jansen believes 100% of the profits from the sale of this book will that ketamine can have be devoted to psychedelic psychotherapy research. potent healing powers when used as an adjunct Ketamine: Dreams and Realities Published by MAPS [Multidisciplinary Association to psychotherapy but warns for Psychedelic Studies] www.maps.org of the addictive nature of ketamine. Because of this risk, he has developed new $14.95 ISBN 0-9660019-7-4 methods for the treatment 51495> of ketamine addiction. Dr. Jansen left Oxford in 1993 to train in psychiatry at With a new preface by the author. the Maudsley and Bethlem 9 780966 001976 Royal Hospitals. He is now a psychiatrist in London. Introduction by Cover photo: Cat’s Eye Nebula; NASA, Hubble Space Telescope MAPS Emanuel Sferios, Founder of DanceSafe Ketamine: Dreams and Realities “It is in my opinion, an excellent book… a well done comprehensive review of the entire history of ketamine!” — Evgeny Krupitsy, M.D. “Ketamine: Dreams and Realities is by far the most authoritative and comprehensive book on the subject of ketamine ever scribed. While the ketamine experience can be vast beyond imagination, Dr. Karl Jansen has managed to capture nearly every facet of this slippery beast in fine detail. Going well beyond an introductory text for the ketamine novice, Dreams and Realities explores in depth both the shimmering insights and existential horrors wrapped up in this elusive molecule. A must read for anyone serious about unraveling ketamine's many mysteries.” — James Kent, TRP Magazine Indispensable reading for those with any interest in ketamine. Entertaining, thought-provoking, and thorough. — Rick Strassman, M.D. i Ketamine: Dreams and Realities Ketamine: Dreams and Realities Ketamine: Dreams and Realities ii iii Ketamine: Dreams and Realities Ketamine: Dreams and Realities Ketamine: Dreams and Realities ISBN 0-9660019-7-4 Ketamine: Copyright ©2000, 2004 by Karl L.R. Jansen, M.D., Ph.D. Dreams and Realities All rights reserved. No part of the contents of this book may be reproduced in any form or by any means without written permission of the publisher. Inquires welcome. Published by: Multidisciplinary Association for Psychedelic Studies (MAPS) 2105 Robinson Avenue Sarasota, FL 34232 USA voice: (941) 924-6277 fax: (941) 924-6265 e-mail: [email protected] web site: http://www.maps.org Editor: Jon Hanna Project Coordinators: Carla Higdon, Brandy Doyle Indexing: Mercedes Paulino Cover & Book Design: Mark Plummer Printed in the United States of America Karl L.R. Jansen, M.D., Ph.D. Text set in Adobe Sabon, Palatino, and Emigré Tarzana. iv v Ketamine: Dreams and Realities Ketamine: Dreams and Realities Table of Contents Preface to the Second Edition ix Introduction 9 Prologue 13 Part I : The Light Within 1. Introduction: K Waves and K Raves 23 2. The Priestess and The Psychonaut: Marcia Moore and John C. Lilly 50 3. Dreams and Realities 71 4. Ketamine, Near-Death, and Near-Birth Experiences 92 5. The Metaphorical Mental Modem 137 Part II: The Dark Side 6. Ketamine Dependence (Addiction) 166 7. Exit from Planet K: The Treatment of Ketamine Dependence 203 8. Journeys into the Fright World: Ketamine and Mental Health 224 9. The Body Electric: Physical Effects and Harm Minimization 266 Part III: Unity 10. Psychedelic Healing 282 References 302 Index 336 vi vii Ketamine: Dreams and Realities Ketamine: Dreams and Realities Preface to the Second Edition Since this book first went to press at the end of the year 2000, the realization that ketamine is a fascinating substance has spread rapidly through several spheres. These include academic research, the dance culture, anesthesia and emergency medicine, psychonaut pioneers, and many others. This generated an unexpected demand for the book, and supplies were soon exhausted. We now find ourselves heading toward the second printing to meet the demand for Ketamine: Dreams and Realities, even though the book was rarely for sale in bookstores and never had a distributor. An important reason for the wider interest in this book may have been that it addresses considerably more than just ketamine: its scope includes fundamental questions about the nature of the psychedelic experience, drug-induced spirituality, and the near-death experience, while also addressing more practical issues, such as the true nature of ‘drug-induced psychosis,’ and the forces which drive drug dependence (and how to defeat them). Ketamine was invented in 1962. By late 2000, there were about 6,500 papers in the Medline/PubMed database about ketamine. Just three years later, there are 8,400 papers – an increase of almost 30%. This is mostly the result of a massive revival of interest in ketamine by anaesthetists, emergency doctors, and pain specialists, due to the ex- cellent safety profile of the drug. Relatively few countries have chosen to follow the USA and Australia into making ketamine a controlled drug, although the World Health Organization/United Nations is con- tinuing to mull the question. However, despite this avalanche of papers appearing since 2000, there are few truly new findings that require a mention. Many of the ‘new’ publications are covering old ground. So while I was originally planning an entirely new book called Ketamine Reconsidered, I have decided to wait until there have been more important advances and changes. I have included a list of some interesting new references be- viii ix Ketamine: Dreams and Realities Ketamine: Dreams and Realities low, which should be added to the 600 on which this book is based. New References of Interest Most of the research since 2000 has continued to emphasise the Breitmeier D., Passie T., Mansouri F., Albrecht K., Kleemann W.J. safety of ketamine, especially in children and in emergency settings. (2002) “Autoerotic accident associated with self-applied ket- The key development in the dance culture has been a move interna- amine,” International Journal of Legal Medecine 116(2):1136. tionally toward sourcing cheap ketamine from factories in China, and the rapid growth of ketamine as a recreational drug throughout Asia. Dillon P., Copeland J. & K.L.R. Jansen (2003) “Patterns of use and A test of urine samples from a rave party in Taiwan found that nearly harms associated with non-medical ketamine use,” Alcohol and half were positive for ketamine (Lua et al. 2003). Drug Dependence 69 (1): 23-28. There is still no evidence that ketamine can cause ‘Olney’s lesions’ in primates. These experimentally-induced brain cell changes appear Gough, N. (2003) “Ketamine: China’s other white powder,” to be confined to small brains, such as those of rats, which have a high Time Asia.com metabolic rate. Studies of memory and other cognitive functions in http://www.time.com/time/asia/covers/1101020520/ketamine.html. ketamine users still suffer from many methodological flaws, for in- Gross S.R., Barrett S.P., Shestowsky J.S., Pihl R.O. (2002) “Ecstasy stance failing to provide urine test results to prove that subjects were and drug consumption patterns: a Canadian rave population not affected by drugs at the time of the testing. study,” Canadian Journal of Psychiatry 47(6): 546-51. However, the period since this book was first published has seen one landmark event in the history of ketamine: the passing of pioneer Hocking G., Cousins M.J. (2003) “Ketamine in chronic pain psychonaut and neuroscientist Dr. John Lilly in September 2001, aged management: an evidence-based review,” Anesthesia and 86. Dr. Lilly was the world’s most famous self-experimenter with ket- Analgesia 97(6): 1730-9. amine and flotation tanks, and a saver of dolphins. He was the model Huddy N.C. & K. Kiff (2004) Preservative-free ketamine. for films such as Altered States and The Day of The Dolphin. Curi- British Journal of Anaesthesiology 92(1): 152. ously, the ‘official’ obituaries in many newspapers entirely failed to mention the central role that self-experimentation with ketamine played Jansen K.L.R. (2000) “A review of the non-medical use of ketamine: in John’s life for thirty years.
Recommended publications
  • Inclusion of People of Color in Psychedelic-Assisted Psychotherapy

    Inclusion of People of Color in Psychedelic-Assisted Psychotherapy

    Michaels et al. BMC Psychiatry (2018) 18:245 https://doi.org/10.1186/s12888-018-1824-6 RESEARCH ARTICLE Open Access Inclusion of people of color in psychedelic- assisted psychotherapy: a review of the literature Timothy I. Michaels1* , Jennifer Purdon1,2, Alexis Collins1 and Monnica T. Williams1,2 Abstract Background: Despite renewed interest in studying the safety and efficacy of psychedelic-assisted psychotherapy for the treatment of psychological disorders, the enrollment of racially diverse participants and the unique presentation of psychopathology in this population has not been a focus of this potentially ground-breaking area of research. In 1993, the United States National Institutes of Health issued a mandate that funded research must include participants of color and proposals must include methods for achieving diverse samples. Methods: A methodological search of psychedelic studies from 1993 to 2017 was conducted to evaluate ethnoracial differences in inclusion and effective methods of recruiting peopple of color. Results: Of the 18 studies that met full criteria (n = 282 participants), 82.3% of the participants were non-Hispanic White, 2.5% were African-American, 2.1% were of Latino origin, 1.8% were of Asian origin, 4.6% were of indigenous origin, 4.6% were of mixed race, 1.8% identified their race as “other,” and the ethnicity of 8.2% of participants was unknown. There were no significant differences in recruitment methodologies between those studies that had higher (> 20%) rates of inclusion. Conclusions: As minorities are greatly underrepresented in psychedelic medicine studies, reported treatment outcomes may not generalize to all ethnic and cultural groups.
  • 4/23/2015 1 •Psychedelics Or Hallucinogens

    4/23/2015 1 •Psychedelics Or Hallucinogens

    4/23/2015 Hallucinogens •Psychedelics or This “classic” hallucinogen column The 2 groups below are quite different produce similar effects From the classic hallucinogens Hallucinogens Drugs Stimulating 5HT Receptors Drugs BLOCKING ACH Receptors • aka “psychotomimetics” LSD Nightshade(Datura) Psilocybin Mushrooms Jimsonweed Morning Glory Seeds Atropine Dimethyltryptamine Scopolamine What do the very mixed group of hallucinogens found around the world share in common? •Drugs Resembling NE Drugs BLOCKING Glutamate Receptors •Peyote cactus Phencyclidine (PCP) •Mescaline Ketamine All contain something that resembles a •Methylated amphetamines like MDMA High dose dextromethorphan •Nutmeg neurotransmitter •New synthetic variations (“bath salts”) •5HT-Like Hallucinogens •LSD History • Serotonin • created by Albert Hofmann for Sandoz Pharmaceuticals LSD • was studying vasoconstriction produced by ergot alkaloids LSD • initial exposure was accidental absorption thru skin • so potent ED is in millionths of a gram (25-250 micrograms) & must be delivered on something else (sugar cube, gelatin square, paper) Psilocybin Activate 5HT2 receptors , especially in prefrontal cortex and limbic areas, but is not readily metabolized •Characteristics of LSD & Other “Typical” •Common Effects Hallucinogens • Sensory distortions (color, size, shape, movement), • Autonomic (mostly sympathetic) changes occur first constantly changing (relatively mild) • Vivid closed eye imagery • Sensory/perceptual changes follow • Synesthesia (crossing of senses – e.g. hearing music
  • Index Vol. 12-15

    Index Vol. 12-15

    353 INDEX VOL. 12-15 Die Stichworte des Sachregisters sind in der jeweiligen Sprache der einzelnen Beitrage aufgefiihrt. Les termes repris dans la Table des matieres sont donnes selon la langue dans laquelle l'ouvrage est ecrit. The references of the Subject Index are given in the language of the respective contribution. 14 AAG (Alpha-acid glycoprotein) 120 14 Adenosine 108 12 Abortion 151 12 Adenosine-phosphate 311 13 Abscisin 12, 46, 66 13 Adenosine-5'-phosphosulfate 148 14 Absorbierbarkeit 317 13 Adenosine triphosphate 358 14 Absorption 309, 350 15 S-Adenosylmethionine 261 13 Absorption of drugs 139 13 Adipaenin (Spasmolytin) 318 14 - 15 12 Adrenal atrophy 96 14 Absorptionsgeschwindigkeit 300, 306 14 - 163, 164 14 Absorptionsquote 324 13 Adrenal gland 362 14 ACAI (Anticorticocatabolic activity in­ 12 Adrenalin(e) 319 dex) 145 14 - 209, 210 12 Acalo 197 15 - 161 13 Aceclidine (3-Acetoxyquinuclidine) 307, 13 {i-Adrenergic blockers 119 308, 310, 311, 330, 332 13 Adrenergic-blocking activity 56 13 Acedapsone 193,195,197 14 O(-Adrenergic blocking drugs 36, 37, 43 13 Aceperone (Acetabutone) 121 14 {i-Adrenergic blocking drugs 38 12 Acepromazin (Plegizil) 200 14 Adrenergic drugs 90 15 Acetanilid 156 12 Adrenocorticosteroids 14, 30 15 Acetazolamide 219 12 Adrenocorticotropic hormone (ACTH) 13 Acetoacetyl-coenzyme A 258 16,30,155 12 Acetohexamide 16 14 - 149,153,163,165,167,171 15 1-Acetoxy-8-aminooctahydroindolizin 15 Adrenocorticotropin (ACTH) 216 (Slaframin) 168 14 Adrenosterone 153 13 4-Acetoxy-1-azabicyclo(3, 2, 2)-nonane 12 Adreson 252
  • Nightshade”—A Hierarchical Classification Approach to T Identification of Hallucinogenic Solanaceae Spp

    Nightshade”—A Hierarchical Classification Approach to T Identification of Hallucinogenic Solanaceae Spp

    Talanta 204 (2019) 739–746 Contents lists available at ScienceDirect Talanta journal homepage: www.elsevier.com/locate/talanta Call it a “nightshade”—A hierarchical classification approach to T identification of hallucinogenic Solanaceae spp. using DART-HRMS-derived chemical signatures ∗ Samira Beyramysoltan, Nana-Hawwa Abdul-Rahman, Rabi A. Musah Department of Chemistry, State University of New York at Albany, 1400 Washington Ave, Albany, NY, 12222, USA ARTICLE INFO ABSTRACT Keywords: Plants that produce atropine and scopolamine fall under several genera within the nightshade family. Both Hierarchical classification atropine and scopolamine are used clinically, but they are also important in a forensics context because they are Psychoactive plants abused recreationally for their psychoactive properties. The accurate species attribution of these plants, which Seed species identifiction are related taxonomically, and which all contain the same characteristic biomarkers, is a challenging problem in Metabolome profiling both forensics and horticulture, as the plants are not only mind-altering, but are also important in landscaping as Direct analysis in real time-mass spectrometry ornamentals. Ambient ionization mass spectrometry in combination with a hierarchical classification workflow Chemometrics is shown to enable species identification of these plants. The hierarchical classification simplifies the classifi- cation problem to primarily consider the subset of models that account for the hierarchy taxonomy, instead of having it be based on discrimination between species using a single flat classification model. Accordingly, the seeds of 24 nightshade plant species spanning 5 genera (i.e. Atropa, Brugmansia, Datura, Hyocyamus and Mandragora), were analyzed by direct analysis in real time-high resolution mass spectrometry (DART-HRMS) with minimal sample preparation required.
  • Peakal: Protons I Have Known and Loved — Fifty Shades of Grey-Market Spectra

    Peakal: Protons I Have Known and Loved — Fifty Shades of Grey-Market Spectra

    PeakAL: Protons I Have Known and Loved — Fifty shades of grey-market spectra Stephen J. Chapman* and Arabo A. Avanes * Correspondence to: Isomer Design, 4103-210 Victoria St, Toronto, ON, M5B 2R3, Canada. E-mail: [email protected] 1H NMR spectra of 28 alleged psychedelic phenylethanamines from 15 grey-market internet vendors across North America and Europe were acquired and compared. Members from each of the principal phenylethanamine families were analyzed: eleven para- substituted 2,5-dimethoxyphenylethanamines (the 2C and 2C-T series); four para-substituted 3,5-dimethoxyphenylethanamines (mescaline analogues); two β-substituted phenylethanamines; and ten N-substituted phenylethanamines with a 2-methoxybenzyl (NBOMe), 2-hydroxybenzyl (NBOH), or 2,3-methylenedioxybenzyl (NBMD) amine moiety. 1H NMR spectra for some of these compounds have not been previously reported to our knowledge. Others have reported on the composition of “mystery pills,” single-dose formulations obtained from retail shops and websites. We believe this is the first published survey of bulk “research chemicals” marketed and sold as such. Only one analyte was unequivocally misrepresented. This collection of experimentally uniform spectra may help forensic and harm-reduction organizations identify these compounds, some of which appear only sporadically. The complete spectra are provided as supplementary data.[1] Keywords: 1H NMR, drug checking, grey markets, research chemicals, phenylethanamines, N-benzyl phenylethanamines, PiHKAL DOI: http://dx.doi.org/10.16889/isomerdesign-1 Published: 1 August 2015 Version: 1.03 “Once you get a serious spectrum collection, Nevertheless, an inherent weakness of grey markets is the the tendency is to push it as far as you can.”1 absence of regulatory oversight.
  • Cerebellar Toxicity of Phencyclidine

    Cerebellar Toxicity of Phencyclidine

    The Journal of Neuroscience, March 1995, 75(3): 2097-2108 Cerebellar Toxicity of Phencyclidine Riitta N&kki, Jari Koistinaho, Frank Ft. Sharp, and Stephen M. Sagar Department of Neurology, University of California, and Veterans Affairs Medical Center, San Francisco, California 94121 Phencyclidine (PCP), clizocilpine maleate (MK801), and oth- Phencyclidine (PCP), dizocilpine maleate (MK801), and other er NMDA antagonists are toxic to neurons in the posterior NMDA receptor antagonistshave attracted increasing attention cingulate and retrosplenial cortex. To determine if addition- becauseof their therapeutic potential. These drugs have neuro- al neurons are damaged, the distribution of microglial ac- protective properties in animal studies of focal brain ischemia, tivation and 70 kDa heat shock protein (HSP70) induction where excitotoxicity is proposedto be an important mechanism was studied following the administration of PCP and of neuronal cell death (Dalkara et al., 1990; Martinez-Arizala et MK801 to rats. PCP (10-50 mg/kg) induced microglial ac- al., 1990). Moreover, NMDA antagonists decrease neuronal tivation and neuronal HSP70 mRNA and protein expression damage and dysfunction in other pathological conditions, in- in the posterior cingulate and retrosplenial cortex. In ad- cluding hypoglycemia (Nellgard and Wieloch, 1992) and pro- dition, coronal sections of the cerebellar vermis of PCP (50 longed seizures(Church and Lodge, 1990; Faingold et al., 1993). mg/kg) treated rats contained vertical stripes of activated However, NMDA antagonists are toxic to certain neuronal microglial in the molecular layer. In the sagittal plane, the populations in the brain. Olney et al. (1989) demonstratedthat microglial activation occurred in irregularly shaped patch- the noncompetitive NMDA antagonists,PCP, MK801, and ke- es, suggesting damage to Purkinje cells.
  • The Scopic Past and the Ethics of the Gaze

    The Scopic Past and the Ethics of the Gaze

    Ivan Illich Kreftingstr. 16 D - 28203 Bremen THE SCOPIC PAST AND THE ETHICS OF THE GAZE A plea for the historical study of ocular perception Filename and date: SCOPICPU.DOC Status: To be published in: Ivan Illich, Mirror II (working title). Copyright Ivan Illich. For further information please contact: Silja Samerski Albrechtstr.19 D - 28203 Bremen Tel: +49-(0)421-7947546 e-mail: [email protected] Ivan Illich: The Scpoic Past and the ethics of the Gaze 2 Ivan Illich THE SCOPIC PAST AND THE ETHICS OF THE GAZE A plea for the historical study of ocular perception1 We want to treat a perceptual activity as a historical subject. There are histories of the rise and fall of the Roman Empire, of the formation of a working class in Great Britain, of porridge in medieval Europe. We ourselves have explored the history of the experienced (female) body in the West. Now we wish to outline the domain for a history of the gaze - der Blick, le regard, opsis.2 The action of seeing is shaped differently in different epochs. We assume that the gaze can be a human act. Hence, our historical survey is carried out sub specie boni; we wish to explore the possibilities of seeing in the perspective of the good. In what ways is this action ethical? The question arose for us when we saw the necessity of defending the integrity and clarity of our senses - our sense experience - against the insistent encroachments of multimedia from cyberspace. From our backgrounds in history, we felt that we had to resist the dissolution of the past by seemingly sophisticated postmodern catch phrases, for example, the deconstruction of conversation into a process of communication.
  • Programme & Abstracts

    Programme & Abstracts

    The 57th Annual Meeting of the International Association of Forensic Toxicologists. 2nd - 6th September 2019 BIRMINGHAM, UK The ICC Birmingham Broad Street, Birmingham B1 2EA Programme & Abstracts 1 Thank You to our Sponsors PlatinUm Gold Silver Bronze 2 3 Contents Welcome message 5 Committees 6 General information 7 iCC maps 8 exhibitors list 10 Exhibition Hall 11 Social Programme 14 opening Ceremony 15 Schedule 16 Oral Programme MONDAY 2 September 19 TUESDAY 3 September 21 THURSDAY 5 September 28 FRIDAY 6 September 35 vendor Seminars 42 Posters 46 oral abstracts 82 Poster abstracts 178 4 Welcome Message It is our great pleasure to welcome you to TIAFT Gala Dinner at the ICC on Friday evening. On the accompanying pages you will see a strong the UK for the 57th Annual Meeting of scientific agenda relevant to modern toxicology and we The International Association of Forensic thank all those who submitted an abstract and the Toxicologists Scientific Committees for making the scientific programme (TIAFT) between 2nd and 6th a success. Starting with a large Young Scientists September 2019. Symposium and Dr Yoo Memorial plenary lecture by Prof Tony Moffat on Monday, there are oral session topics in It has been decades since the Annual Meeting has taken Clinical & Post-Mortem Toxicology on Tuesday, place in the country where TIAFT was founded over 50 years Human Behaviour Toxicology & Drug-Facilitated Crime on ago. The meeting is supported by LTG (London Toxicology Thursday and Toxicology in Sport, New Innovations and Group) and the UKIAFT (UK & Ireland Association of Novel Research & Employment/Occupational Toxicology Forensic Toxicologists) and we thank all our exhibitors and on Friday.
  • The Complete X-Files Ebook

    The Complete X-Files Ebook

    THE COMPLETE X-FILES PDF, EPUB, EBOOK Chris Knowles,Matt Hurwitz | 224 pages | 23 Sep 2016 | Titan Books Ltd | 9781785654336 | English | London, United Kingdom The Complete X-Files PDF Book In one of the most tongue in cheek, unusual episodes of the series, Scully consults with a Truman Capote-like novelist who wants to write "non- fiction science fiction" based around an unusual x-file, giving an outsider's perspective to a case. You may not need files for most quick fixes. It's an unnerving, calculating episode, where the mere appearance of Modell onscreen spells very bad thing. There's also a lot of heart in the episode, with Boyle portraying a sensitive, gruff loner dealing with the worst of curses. The episode seems to be heavily influenced by the works of H. Essentially, the episode is about the government using television signals to drive people to madness. This not only makes filing faster but makes it much easier to find documents afterward. An FBI manhunt ensues, with agents in pursuit of an antagonist that can alter their very perceptions of reality. The beauty of customizing your filing system this way is that it can always be further subdivided and organized if you need to. This grisly, nightmare-inducing episode about an inbred family of killers was so terrifying and controversial that Fox famously decreed that it would never be aired again after its initial broadcast prompted a flood of complaints from concerned viewers. I could stop at that as a reason to watch, but there's more. You may be able to find the same content in another format, or you may be able to find more information, at their web site.
  • Chapter 1—— IBOGAINE: a REVIEW

    Chapter 1—— IBOGAINE: a REVIEW

    ——Chapter 1—— IBOGAINE: A REVIEW Kenneth R. Alper Departments of Psychiatry and Neurology New York University School of Medicine New York, NY 10016 I. Introduction, Chemical Properties, and Historical Time Line .................................... A. Introduction............................................................................................................ B. Chemical Structure and Properties ........................................................................ C. Historical Time Line.............................................................................................. II. Mechanisms of Action ................................................................................................. A. Neurotransmitter Activities.................................................................................... B. Discrimination Studies........................................................................................... C. Effects on Neuropeptides....................................................................................... D. Possible Effects on Neuroadaptations Related to Drug Sensitization or Tolerance ........................................................................................................... III. Evidence of Efficacy in Animal Models....................................................................... A. Drug Self-Administration ...................................................................................... B. Acute Opioid Withdrawal.....................................................................................
  • Adverse Reactions to Hallucinogenic Drugs. 1Rnstttutton National Test

    Adverse Reactions to Hallucinogenic Drugs. 1Rnstttutton National Test

    DOCUMENT RESUME ED 034 696 SE 007 743 AUTROP Meyer, Roger E. , Fd. TITLE Adverse Reactions to Hallucinogenic Drugs. 1rNSTTTUTTON National Test. of Mental Health (DHEW), Bethesda, Md. PUB DATP Sep 67 NOTE 118p.; Conference held at the National Institute of Mental Health, Chevy Chase, Maryland, September 29, 1967 AVATLABLE FROM Superintendent of Documents, Government Printing Office, Washington, D. C. 20402 ($1.25). FDPS PRICE FDPS Price MFc0.50 HC Not Available from EDRS. DESCPTPTOPS Conference Reports, *Drug Abuse, Health Education, *Lysergic Acid Diethylamide, *Medical Research, *Mental Health IDENTIFIEPS Hallucinogenic Drugs ABSTPACT This reports a conference of psychologists, psychiatrists, geneticists and others concerned with the biological and psychological effects of lysergic acid diethylamide and other hallucinogenic drugs. Clinical data are presented on adverse drug reactions. The difficulty of determining the causes of adverse reactions is discussed, as are different methods of therapy. Data are also presented on the psychological and physiolcgical effects of L.S.D. given as a treatment under controlled medical conditions. Possible genetic effects of L.S.D. and other drugs are discussed on the basis of data from laboratory animals and humans. Also discussed are needs for futher research. The necessity to aviod scare techniques in disseminating information about drugs is emphasized. An aprentlix includes seven background papers reprinted from professional journals, and a bibliography of current articles on the possible genetic effects of drugs. (EB) National Clearinghouse for Mental Health Information VA-w. Alb alb !bAm I.S. MOMS Of NAM MON tMAN IONE Of NMI 105 NUNN NU IN WINES UAWAS RCM NIN 01 NUN N ONMININI 01011110 0.
  • Constructing the Witch in Contemporary American Popular Culture

    Constructing the Witch in Contemporary American Popular Culture

    "SOMETHING WICKED THIS WAY COMES": CONSTRUCTING THE WITCH IN CONTEMPORARY AMERICAN POPULAR CULTURE Catherine Armetta Shufelt A Dissertation Submitted to the Graduate College of Bowling Green State University in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY December 2007 Committee: Dr. Angela Nelson, Advisor Dr. Andrew M. Schocket Graduate Faculty Representative Dr. Donald McQuarie Dr. Esther Clinton © 2007 Catherine A. Shufelt All Rights Reserved iii ABSTRACT Dr. Angela Nelson, Advisor What is a Witch? Traditional mainstream media images of Witches tell us they are evil “devil worshipping baby killers,” green-skinned hags who fly on brooms, or flaky tree huggers who dance naked in the woods. A variety of mainstream media has worked to support these notions as well as develop new ones. Contemporary American popular culture shows us images of Witches on television shows and in films vanquishing demons, traveling back and forth in time and from one reality to another, speaking with dead relatives, and attending private schools, among other things. None of these mainstream images acknowledge the very real beliefs and traditions of modern Witches and Pagans, or speak to the depth and variety of social, cultural, political, and environmental work being undertaken by Pagan and Wiccan groups and individuals around the world. Utilizing social construction theory, this study examines the “historical process” of the construction of stereotypes surrounding Witches in mainstream American society as well as how groups and individuals who call themselves Pagan and/or Wiccan have utilized the only media technology available to them, the internet, to resist and re- construct these images in order to present more positive images of themselves as well as build community between and among Pagans and nonPagans.